The U.S. SEC has dropped its lawsuit against BitClout founder Nader Al-Naji, bringing the $257 million fundraising case to a close
Svmuu News: The U.S. Securities and Exchange Commission (SEC) has withdrawn its civil enforcement action against BitClout founder Nader Al-Naji. According to a joint filing submitted to the court on March 12, the SEC and Al-Naji have agreed to terminate the proceedings. The case will be permanently closed, and the regulator may not file another lawsuit based on the same allegations. The SEC stated that this decision was “based on the specific facts and circumstances of this case.” It is reported that the SEC sued Al-Naji in July 2024, alleging that he committed wire fraud and sold unregistered securities through the cryptocurrency social media project BitClout (later associated with the decentralized social blockchain DeSo). He allegedly raised approximately $257 million by selling BitClout’s native token, BTCLT, and is suspected of using over $7 million in investor funds for personal expenses, including renting a luxury mansion in Beverly Hills. (CoinDesk)
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
3
Will the BEAM token go to zero? Could it rise to $1,000? An in-depth analysis of the Beam network and its market prospects
-
4
The analysis points out that Iran’s overlapping centers of power complicate efforts to end the war with the United States, and that the Revolutionary Guards possess significant operational autonomy.
-
5
Israeli West Bank Settler Tells BBC Attacks on Palestinians Are Justified as Revenge, Equating One Jewish Life to "10 Million" Palestinians
-
6
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
7
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
8
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
9
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
-
10
Analysis: Vanguard Small-Cap Growth ETF (VBK) up 21% YTD 2026, Outperforming Large-Cap Growth ETF (VONG) at 0.3% YTD
Markets Today
Recommended Reading






